Abstract :Transcatheter aortic valves implantation (TAVI) is a valid treatment for high-risk surgical candidates with symptomatic severe aortic stenosis; the safety and effectiveness of TAVI have been demonstrated in numerous clinical studies, national registries and randomized trials. Nevertheless, from this cohort of patients have been often excluded patients with prior mitral valve surgery because concerns exist for possible interference between the trans-catheter aortic valve and the mitral prosthesis.
We describe a case of a Portico™ TAVI system (St Jude Medical, St Paul, MN, USA) made in an 83-year-old patient who previously underwent mitral valve replacement with a mechanical prosthesis.